Nutrien Ltd. (NYSE:NTR) Position Trimmed by Stephens Inc. AR

Stephens Inc. AR reduced its holdings in Nutrien Ltd. (NYSE:NTR) by 3.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 67,918 shares of the company’s stock after selling 2,383 shares during the quarter. Stephens Inc. AR’s holdings in Nutrien were worth $3,039,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of NTR. HHM Wealth Advisors LLC lifted its holdings in Nutrien by 331.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock worth $28,000 after acquiring an additional 480 shares during the last quarter. Exchange Traded Concepts LLC lifted its holdings in shares of Nutrien by 96.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock worth $38,000 after purchasing an additional 416 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new position in Nutrien during the 4th quarter valued at approximately $67,000. Larson Financial Group LLC grew its stake in Nutrien by 1,370.6% during the 3rd quarter. Larson Financial Group LLC now owns 1,603 shares of the company’s stock worth $77,000 after buying an additional 1,494 shares during the last quarter. Finally, Cromwell Holdings LLC increased its position in Nutrien by 113.4% in the third quarter. Cromwell Holdings LLC now owns 1,694 shares of the company’s stock worth $82,000 after buying an additional 900 shares during the period. 63.10% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

NTR has been the subject of several analyst reports. CIBC reissued an “outperformer” rating and set a $55.00 price target (down previously from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. Scotiabank raised their price target on shares of Nutrien from $59.00 to $60.00 and gave the company a “sector outperform” rating in a research note on Monday. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. JPMorgan Chase & Co. upgraded Nutrien from an “underweight” rating to a “neutral” rating and raised their target price for the company from $40.00 to $50.00 in a research report on Monday, January 13th. Finally, Barclays reaffirmed an “equal weight” rating and set a $56.00 target price (up previously from $55.00) on shares of Nutrien in a research note on Tuesday, January 21st. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $59.00.

Nutrien Stock Down 0.3 %

NYSE NTR opened at $51.82 on Wednesday. Nutrien Ltd. has a 12 month low of $43.69 and a 12 month high of $60.87. The company has a market capitalization of $25.45 billion, a P/E ratio of 34.78, a PEG ratio of 1.13 and a beta of 0.81. The company’s 50 day simple moving average is $48.81 and its 200 day simple moving average is $48.10. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.